Edecesertib

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Cutaneous Lupus ErythematosusCutaneous Lupus Erythematosus (CLE)

Phase 1

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

TerminatedNCT04809623

Gilead SciencesCutaneous Lupus Erythematosus

Start: 2021-09-01End: 2022-10-18Updated: 2024-04-05

Phase 2

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

TerminatedNCT05629208

Gilead SciencesCutaneous Lupus Erythematosus (CLE)

Start: 2023-04-17End: 2026-01-14Updated: 2026-02-17